Bortezomib Therapy in Patients With Relapsed or Refractory Lymphoma: Potential Correlation of In Vitro Sensitivity and Tumor Necrosis Factor Alpha Response With Clinical Activity Early studies ...

Triple-negative breast cancer does not respond to targeted breast cancer treatments, which limits treatment to primarily chemotherapy for now.

A research team has led a groundbreaking study that delves into the exploration of triple-negative apocrine carcinoma. Breast cancer research takes a significant stride forward as Professor Semin Lee ...

Background Malnutrition influences prognosis in patients with heart failure, but current nutritional evaluation methods are ...

The article by Rodrigues et al, entitled "Prognosis of T1ab Node-Negative Human Epidermal Growth Factor Receptor 2–Positive Breast Carcinomas" (J Clin Oncol 33:291-292, 2015), was published online ...

According to an international multicenter study, CD2-negative mast cells are associated with significantly reduced overall survival in patients with SM. Patients with CD2-negative mast cells have ...